Mitchall Clark

Mitchall Clark

Generell Rådgivare på WHITEHAWK THERAPEUTICS, INC.
65 år
Health Technology
Consumer Services
Technology Services

Profil

Mitchall G.
Clark
is a Senior VP-Regulatory Affairs & Quality Assurance at Aadi Bioscience, Inc. He previously held positions as Senior Director-Regulatory Affairs at Faulding, Inc. and American Bioscience, Inc., Vice President-Regulatory Affairs at APP Pharmaceuticals, Inc., Senior Vice President-Global Regulatory Affairs at Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs at Celgene Corp., NantWorks LLC, and Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs & Quality at NantPharma LLC, and Chief Regulatory & Quality Assurance Officer at Atara Biotherapeutics, Inc. He also worked as a Principal at Lindum Pharmaceutical Services Corp.
Mr. Clark received an undergraduate degree from The University of Nottingham.

Aktiva positioner av Mitchall Clark

FöretagPositionStart
WHITEHAWK THERAPEUTICS, INC. Generell Rådgivare 2018-08-01

Tidigare kända positioner av Mitchall Clark

FöretagPositionSlut
Lindum Pharmaceutical Services Corp.
Företagsledare/Principal 2014-03-01
Generell Rådgivare 2013-06-01
CELGENE Generell Rådgivare 2011-06-01
Generell Rådgivare 2007-11-01
Generell Rådgivare 2006-04-01
Se detaljerna i Mitchall Clarks erfarenhet

Mitchall Clarks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

53

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Lindum Pharmaceutical Services Corp.

Health Technology

  1. Börsen
  2. Insiders
  3. Mitchall Clark
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU